Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.

El-Zein M, Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, Colares de Borba P, Teixeira JC, Moscicki AB, Harper DM, Tyring SK, Ramjattan B, Dubin G, Franco EL; HPV-007 Study Group.

Sex Transm Dis. 2019 Oct;46(10):663-669. doi: 10.1097/OLQ.0000000000001053.

PMID:
31464859
2.

Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.

Moscicki AB, Yao TJ, Russell JS, Farhat S, Scott M, Magpantay L, Halec G, Shiboski CH, Ryder MI; Pediatric HIV/AIDS Cohort Study.

J Clin Periodontol. 2019 Aug 6. doi: 10.1111/jcpe.13179. [Epub ahead of print]

PMID:
31385616
3.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S Jr, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM.

Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13.

4.

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.

Zeng Y, Moscicki AB, Sahasrabuddhe VV, Garcia F, Woo H, Hsu CH, Szabo E, Dimond E, Vanzzini S, Mondragon A, Butler V, DeRose H, Chow HS.

BMC Cancer. 2019 Apr 1;19(1):290. doi: 10.1186/s12885-019-5444-4.

5.

Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.

Moscicki AB, Karalius B, Tassiopoulos K, Yao TJ, Jacobson DL, Patel K, Purswani M, Seage GR; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2019 Sep 13;69(7):1183-1191. doi: 10.1093/cid/ciy1040.

PMID:
30927547
6.

Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.

Moscicki AB, Flowers L, Huchko MJ, Long ME, MacLaughlin KL, Murphy J, Spiryda LB, Gold MA.

J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468.

PMID:
30907775
7.

Bayesian variable selection for multivariate zero-inflated models: Application to microbiome count data.

Lee KH, Coull BA, Moscicki AB, Paster BJ, Starr JR.

Biostatistics. 2018 Dec 26. doi: 10.1093/biostatistics/kxy067. [Epub ahead of print]

PMID:
30590511
8.

Resting-state brain network features associated with short-term skill learning ability in humans and the influence of N-methyl-d-aspartate receptor antagonism.

Zang Z, Geiger LS, Braun U, Cao H, Zangl M, Schäfer A, Moessnang C, Ruf M, Reis J, Schweiger JI, Dixson L, Moscicki A, Schwarz E, Meyer-Lindenberg A, Tost H.

Netw Neurosci. 2018 Oct 1;2(4):464-480. doi: 10.1162/netn_a_00045. eCollection 2018.

9.

Should Cervical Cancer Screening be Performed Before the Age of 25 Years?

Moscicki AB, Perkins RB, Saville M, Brotherton JML.

J Low Genit Tract Dis. 2018 Oct;22(4):348-351. doi: 10.1097/LGT.0000000000000434. No abstract available.

10.

Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention.

Kim SC, Feldman S, Moscicki AB.

Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v26-v33. doi: 10.1093/rheumatology/kex523.

11.

Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.

Halec G, Scott ME, Farhat S, Darragh TM, Moscicki AB.

Int J Cancer. 2018 Dec 1;143(11):2884-2891. doi: 10.1002/ijc.31814. Epub 2018 Oct 9.

PMID:
30121951
12.

The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth.

Shiboski CH, Yao TJ, Russell JS, Ryder MI, Van Dyke RB, Seage GR 3rd, Moscicki AB; Pediatric HIV/AIDS Cohort Study.

AIDS. 2018 Nov 13;32(17):2497-2505. doi: 10.1097/QAD.0000000000001965.

PMID:
30096069
13.

Oral microbiota in youth with perinatally acquired HIV infection.

Starr JR, Huang Y, Lee KH, Murphy CM, Moscicki AB, Shiboski CH, Ryder MI, Yao TJ, Faller LL, Van Dyke RB, Paster BJ; Pediatric HIV/AIDS Cohort Study.

Microbiome. 2018 May 31;6(1):100. doi: 10.1186/s40168-018-0484-6.

14.

IPVS statement moving towards elimination of cervical cancer as a public health problem.

Garland SM, Giuliano A, Brotherton J, Moscicki AB, Stanley M, Kaufmann AM, Bhatla N, Sankaranarayanan R, Palefsky JM, de Sanjose S; IPVS.

Papillomavirus Res. 2018 Jun;5:87-88. doi: 10.1016/j.pvr.2018.02.003. Epub 2018 Feb 27. No abstract available.

15.

Trends in Cervical Cancer Screening in California's Family Planning Program.

Thiel de Bocanegra H, Navarro SK, Nonzee NJ, Vangala S, Zhou X, Chang C, Moscicki AB.

J Low Genit Tract Dis. 2018 Jul;22(3):171-177. doi: 10.1097/LGT.0000000000000376.

16.

Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.

Weinberg A, Huang S, Moscicki AB, Saah A, Levin MJ; IMPAACT P1085 Protocol Team.

AIDS. 2018 Apr 24;32(7):851-860. doi: 10.1097/QAD.0000000000001773.

17.

HPV vaccination of immunocompromised hosts.

Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, Sankaranarayanan R, de Sanjosé S, Palefsky JM; IPVS.

Papillomavirus Res. 2017 Dec;4:35-38. doi: 10.1016/j.pvr.2017.06.002. Epub 2017 Jun 3.

18.

ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice.

Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ Jr, Waxman AG, Conageski C, Einstein MH, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):223-229. doi: 10.1097/LGT.0000000000000338. Review.

PMID:
28953110
19.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):216-222. doi: 10.1097/LGT.0000000000000322.

PMID:
28953109
20.

Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples.

Moscicki AB, Ma Y, Gheit T, McKay-Chopin S, Farhat S, Widdice LE, Tommasino M.

Open Forum Infect Dis. 2017 Jan 31;4(1):ofw216. doi: 10.1093/ofid/ofw216. eCollection 2017 Winter.

21.

Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.

Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS.

J Low Genit Tract Dis. 2017 Apr;21(2):87-90. doi: 10.1097/LGT.0000000000000300. No abstract available.

22.

Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.

Levin MJ, Huang S, Moscicki AB, Song LY, Read JS, Meyer WA, Saah AJ, Richardson K, Weinberg A; IMPAACT P1085 Protocol Team.

Vaccine. 2017 Mar 23;35(13):1712-1720. doi: 10.1016/j.vaccine.2017.02.021. Epub 2017 Feb 24.

23.

The effect of intrauterine devices on acquisition and clearance of human papillomavirus.

Averbach SH, Ma Y, Smith-McCune K, Shiboski S, Moscicki AB.

Am J Obstet Gynecol. 2017 Apr;216(4):386.e1-386.e5. doi: 10.1016/j.ajog.2016.11.1053. Epub 2016 Dec 14.

24.

Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV-infected and HIV-exposed and uninfected youth.

Ryder MI, Yao TJ, Russell JS, Moscicki AB, Shiboski CH; Pediatric HIV/AIDS Cohort Study.

J Clin Periodontol. 2017 Jan;44(1):2-12. doi: 10.1111/jcpe.12646. Epub 2016 Nov 22.

25.

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, de Borba PC, Teixeira JC, Blatter M, Moscicki AB, Harper DM, Romanowski B, Tyring SK, Ramjattan B, Schuind A, Dubin G, Franco EL; HPV-007 Study Group.

BMJ Open. 2016 Aug 26;6(8):e011371. doi: 10.1136/bmjopen-2016-011371. Erratum in: BMJ Open. 2016 Sep 02;6(9):e011371corr1.

26.

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study.

Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, Rivera B, Ramírez P, Mendiola-Pastrana I, Rudolph SE, León-Maldonado L, Hernández R, Barrios E, Gravitt P, Moscicki AB, Schmeler KM, Flores YN, Méndez-Hernández P, Salmerón J; FRIDA Study Group.

Salud Publica Mex. 2016 Apr;58(2):197-210.

PMID:
27557378
27.

Does the vaginal microbiota play a role in the development of cervical cancer?

Kyrgiou M, Mitra A, Moscicki AB.

Transl Res. 2017 Jan;179:168-182. doi: 10.1016/j.trsl.2016.07.004. Epub 2016 Jul 15. Review.

28.

Oral Human Papillomavirus in Youth From the Pediatric HIV/AIDS Cohort Study.

Moscicki AB, Farhat S, Yao TJ, Ryder MI, Russell JS, Van Dyke RB, Hazra R, Shiboski CH; Pediatric HIVAIDS Cohort Study.

Sex Transm Dis. 2016 Aug;43(8):498-500. doi: 10.1097/OLQ.0000000000000495.

29.

The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth.

Moscicki AB, Yao TJ, Ryder MI, Russell JS, Dominy SS, Patel K, McKenna M, Van Dyke RB, Seage GR 3rd, Hazra R; Shiboski.

PLoS One. 2016 Jun 14;11(6):e0156459. doi: 10.1371/journal.pone.0156459. eCollection 2016.

30.

Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Speicher DJ, Ramirez-Amador V, Dittmer DP, Webster-Cyriaque J, Goodman MT, Moscicki AB.

Oral Dis. 2016 Apr;22 Suppl 1:181-92. doi: 10.1111/odi.12418.

31.

HPV vaccination for victims of childhood sexual abuse.

Garland SM, Subasinghe AK, Jayasinghe YL, Wark JD, Moscicki AB, Singer A, Bosch X, Cusack K, Stanley M.

Lancet. 2015 Nov 14;386(10007):1919-20. doi: 10.1016/S0140-6736(15)00757-6. Epub 2015 Nov 13. No abstract available.

PMID:
26841735
32.

Screening for Anal Cancer in Women.

Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM.

J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117. Review.

33.

Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.

Hwang LY, Scott ME, Ma Y, Moscicki AB.

Am J Reprod Immunol. 2015 Sep;74(3):228-36. doi: 10.1111/aji.12401. Epub 2015 May 20.

34.

Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies.

Farhat S, Scott ME, Ma Y, Moscicki AB.

J Clin Microbiol. 2015 Apr;53(4):1270-6. doi: 10.1128/JCM.03100-14. Epub 2015 Feb 4.

35.

Biological and behavioral risks for incident Chlamydia trachomatis infection in a prospective cohort.

Hwang LY, Ma Y, Moscicki AB.

Obstet Gynecol. 2014 Nov;124(5):954-60. doi: 10.1097/AOG.0000000000000429.

36.

Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response.

Scott ME, Ma Y, Farhat S, Moscicki AB.

Int J Cancer. 2015 May 15;136(10):2402-8. doi: 10.1002/ijc.29283. Epub 2014 Oct 30.

37.

Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages.

Zhang C, Park JS, Grce M, Hibbitts S, Palefsky JM, Konno R, Smith-McCune KK, Giovannelli L, Chu TY, Picconi MA, Piña-Sánchez P, Settheetham-Ishida W, Coutlée F, De Marco F, Woo YL, Ho WC, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Sabol I, Fiander AN, Chen Z, Chan MC, Cheung TH, Burk RD, Chan PK.

J Infect Dis. 2014 Nov 15;210(10):1600-4. doi: 10.1093/infdis/jiu310. Epub 2014 May 30.

38.

Human papillomavirus infections in nonsexually active perinatally HIV infected children.

Moscicki AB, Puga A, Farhat S, Ma Y.

AIDS Patient Care STDS. 2014 Feb;28(2):66-70. doi: 10.1089/apc.2013.0313. Epub 2014 Jan 24.

39.

Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence.

Moscicki AB, Ma Y, Farhat S, Jay J, Hanson E, Benningfield S, Jonte J, Godwin-Medina C, Wilson R, Shiboski S.

Clin Infect Dis. 2014 Mar;58(6):804-11. doi: 10.1093/cid/cit947. Epub 2013 Dec 23.

40.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 31;31 Suppl 7:H1-31. doi: 10.1016/j.vaccine.2013.10.003.

PMID:
24332295
41.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 30;31 Suppl 6:G1-31. doi: 10.1016/j.vaccine.2013.10.002. Review.

PMID:
24331817
42.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Review.

PMID:
24331745
43.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Nov 22;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026. Review.

44.

Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth.

Alperen J, Brummel S, Tassiopoulos K, Mellins CA, Kacanek D, Smith R, Seage GR 3rd, Moscicki AB.

J Adolesc Health. 2014 Mar;54(3):341-9. doi: 10.1016/j.jadohealth.2013.09.003. Epub 2013 Nov 13.

45.

Higher calorie diets increase rate of weight gain and shorten hospital stay in hospitalized adolescents with anorexia nervosa.

Garber AK, Mauldin K, Michihata N, Buckelew SM, Shafer MA, Moscicki AB.

J Adolesc Health. 2013 Nov;53(5):579-84. doi: 10.1016/j.jadohealth.2013.07.014. Epub 2013 Sep 17.

46.

Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.

Moscicki AB, Ma Y, Farhat S, Darragh TM, Pawlita M, Galloway DA, Shiboski S.

J Infect Dis. 2013 Aug 1;208(3):403-12. doi: 10.1093/infdis/jit175. Epub 2013 Apr 18.

47.

Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Scott ME, Shvetsov YB, Thompson PJ, Hernandez BY, Zhu X, Wilkens LR, Killeen J, Vo DD, Moscicki AB, Goodman MT.

Int J Cancer. 2013 Sep 1;133(5):1187-96. doi: 10.1002/ijc.28119. Epub 2013 Mar 16.

48.

Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals.

Widdice L, Ma Y, Jonte J, Farhat S, Breland D, Shiboski S, Moscicki AB.

J Infect Dis. 2013 Apr 15;207(8):1286-94. doi: 10.1093/infdis/jit018. Epub 2013 Jan 14.

49.

Updating the natural history of human papillomavirus and anogenital cancers.

Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J.

Vaccine. 2012 Nov 20;30 Suppl 5:F24-33. doi: 10.1016/j.vaccine.2012.05.089. Review.

50.

Human papillomavirus, human immunodeficiency virus and immunosuppression.

Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J.

Vaccine. 2012 Nov 20;30 Suppl 5:F168-74. doi: 10.1016/j.vaccine.2012.06.045. Review.

PMID:
23199960

Supplemental Content

Loading ...
Support Center